Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.24	70.62	69.07
Graham Fair Price	6.07	65.89	62.11
PEG	55.08	2.33	-1.50
Price/Book	-9.06	2.44	2.69
Price/Cash Flow	163.99	145.11	54.97
Prices/Earnings	-19.82	31.15	38.85
Price/Sales	-9.67	11.28	12.48
Price/FCF	163.99	145.11	54.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.43	0.32	0.33
Operating Margin	-14.43	0.11	0.13
ROA	14.48	0.01	0.01
ROE	0.02	0.02	13.41
ROIC	0.01	0.02	3.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.10	94.44
Dividends QOQ	< 0.005	< 0.005	189.14
EBIT QOQ	-0.28	-0.14	48.62
EPS QOQ	-0.26	0.13	-48.29
FCF QOQ	-0.13	-0.66	-393.37
Revenue QOQ	-0.12	< 0.005	-97.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.90	112.97	-5.78
Days Sales Outstanding (DSO)	48.39	49.74	2.78
Inventory Turnover	0.75	0.80	6.14
Debt/Capitalization	0.26	0.26	-0.25
Quick Ratio	2.24	2.12	-5.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	99.59	99.19	-0.39
Cash	22.31	22.58	1.17
Capex	-0.92	-0.62	32.49
Free Cash Flow	4.87	1.67	-65.69
Revenue	21.43	21.49	0.27
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.75	3.57	-4.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.71	4.05	8.98
Naive Interpretation	Member

06 - Financial Health · Bad

Rating